Scottish Medicines Consortium

The Scottish Medicines Consortium (SMC) was established in 2001 with the remit to provide advice to NHS Boards and their Area Drug and Therapeutics Committees across Scotland about the status of all newly licensed medicines, all new formulations of existing medicines and any major new indications for established products. The SMC process (full details of which are available on their website http //www.scottishmedicines.org.uk/) requires pharmaceutical companies to complete a new product submission form. The aim is to make a recommendation soon after the launch... 

NHS Scotland. Scottish Medicines consortium Annual Report 2003-2004. 

Anne Lee, MPhil, MRPharmS Principal Pharmacist, Horizon Scanning, Scottish Medicines Consortium, NHS Quality Improvement Scotland, Delta House (8th floor), 50 West Nile Street, Glasgow G1 2NP, Scotland, UK... 

Example bortezomib For the multiple myeloma indication, in the UK the manufacturer agreed in 2007 to reimburse the NHS in either cash or product for patients who did not respond, i.e. those who do not show a 50 % decrease in serum M protein, after four cycles. Responding patients received additional four cycles. In 2009, the same agreement was fixed with the Scottish Medicines Consortium. 

---